James Mulay, Director at CG Oncology, Inc. (CGON), sold 1,964 shares at $63.50 ($125K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Scheduled sale ($125k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.50 | 654 | $42K | 33.3% |
| 2 | $63.50 | 1,310 | $83K | 66.7% |
| Total | $63.50 avg | 1,964 | $125K | 100% |
| Filing → |
| CGON | SELL | 2026-04-20 | $1.1M | — | Filing → |
| CGON | SELL | 2026-01-13 | $585K | — | Filing → |
| CGON | SELL | 2025-10-10 | $519K | — | Filing → |